We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Top Sells

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$173M
2
SPG icon
Simon Property Group
SPG
+$154M
3
WELL icon
Welltower
WELL
+$114M
4
AMT icon
American Tower
AMT
+$96.9M
5
ELS icon
Equity Lifestyle Properties
ELS
+$88M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
1126
MannKind Corp
MNKD
$1.19B
$5K ﹤0.01%
1,058
– –
SPRY icon
1127
ARS Pharmaceuticals
SPRY
$579M
$5K ﹤0.01%
367
– –
TVTX icon
1128
Travere Therapeutics
TVTX
$5.17B
$5K ﹤0.01%
258
– –
XLI icon
1129
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
$5K ﹤0.01%
38
-3
-7% -$405
XLV icon
1130
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$5K ﹤0.01%
35
+14
+67% +$2.03K
ADPT icon
1131
Adaptive Biotechnologies
ADPT
$3.61B
$4K ﹤0.01%
530
– –
ARDX icon
1132
Ardelyx
ARDX
$1.24B
$4K ﹤0.01%
754
– –
AUPH icon
1133
Aurinia Pharmaceuticals
AUPH
$1.95B
$4K ﹤0.01%
528
– –
CNTA
1134
DELISTED
Centessa Pharmaceuticals
CNTA
$4K ﹤0.01%
294
– –
COLL icon
1135
Collegium Pharmaceutical
COLL
$1.18B
$4K ﹤0.01%
127
– –
DYN icon
1136
Dyne Therapeutics
DYN
$4.15B
$4K ﹤0.01%
371
– –
ETNB
1137
DELISTED
89bio
ETNB
$4K ﹤0.01%
499
+155
+45% +$1.35K
GERN icon
1138
Geron
GERN
$898M
$4K ﹤0.01%
2,247
– –
GPCR icon
1139
Structure Therapeutics
GPCR
$3.37B
$4K ﹤0.01%
226
– –
IMCR icon
1140
Immunocore
IMCR
$1.7B
$4K ﹤0.01%
138
– –
INDV icon
1141
Indivior Pharmaceuticals
INDV
$4.74B
$4K ﹤0.01%
450
– –
INVA icon
1142
Innoviva
INVA
$1.6B
$4K ﹤0.01%
238
– –
NVAX icon
1143
Novavax
NVAX
$1.21B
$4K ﹤0.01%
652
– –
OCUL icon
1144
Ocular Therapeutix
OCUL
$1.83B
$4K ﹤0.01%
593
– –
PCRX icon
1145
Pacira BioSciences
PCRX
$1.04B
$4K ﹤0.01%
169
– –
SNDX icon
1146
Syndax Pharmaceuticals
SNDX
$1.7B
$4K ﹤0.01%
314
– –
VERA icon
1147
Vera Therapeutics
VERA
$2.33B
$4K ﹤0.01%
182
– –
WVE icon
1148
Wave Life Sciences
WVE
$1.12B
$4K ﹤0.01%
503
– –
XLC icon
1149
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$4K ﹤0.01%
42
-19
-31% -$1.9K
ABCL icon
1150
AbCellera Biologics
ABCL
$1.65B
$3K ﹤0.01%
1,151
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.